

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | blood coagulation, intrinsic pathway (GO:0007597) | 6.09252326 |
| 2 | negative regulation of complement activation (GO:0045916) | 5.77211964 |
| 3 | retinal cone cell development (GO:0046549) | 5.70049455 |
| 4 | angiogenesis involved in wound healing (GO:0060055) | 5.68657418 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.51423217 |
| 6 | negative regulation of protein activation cascade (GO:2000258) | 5.34249210 |
| 7 | protein neddylation (GO:0045116) | 5.28897452 |
| 8 | response to magnesium ion (GO:0032026) | 5.27285518 |
| 9 | thrombin receptor signaling pathway (GO:0070493) | 5.20214471 |
| 10 | xenobiotic catabolic process (GO:0042178) | 4.90618703 |
| 11 | regulation of platelet activation (GO:0010543) | 4.78793139 |
| 12 | negative regulation of humoral immune response (GO:0002921) | 4.68272207 |
| 13 | regulation of platelet aggregation (GO:0090330) | 4.66991793 |
| 14 | negative regulation of platelet activation (GO:0010544) | 4.50722719 |
| 15 | lysine metabolic process (GO:0006553) | 4.40293896 |
| 16 | lysine catabolic process (GO:0006554) | 4.40293896 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 4.36407165 |
| 18 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.29860002 |
| 19 | negative regulation of protein localization to cell surface (GO:2000009) | 4.29856370 |
| 20 | negative regulation of heart rate (GO:0010459) | 4.23525176 |
| 21 | response to folic acid (GO:0051593) | 4.21703239 |
| 22 | reverse cholesterol transport (GO:0043691) | 4.19902277 |
| 23 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 4.19041710 |
| 24 | negative regulation of T-helper cell differentiation (GO:0045623) | 4.04416816 |
| 25 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 4.04416816 |
| 26 | response to misfolded protein (GO:0051788) | 4.00649243 |
| 27 | beta-amyloid metabolic process (GO:0050435) | 3.99415073 |
| 28 | negative regulation of norepinephrine secretion (GO:0010700) | 3.95752671 |
| 29 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.95441404 |
| 30 | alkaloid metabolic process (GO:0009820) | 3.86047612 |
| 31 | negative regulation of response to food (GO:0032096) | 3.85131546 |
| 32 | negative regulation of appetite (GO:0032099) | 3.85131546 |
| 33 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.84896018 |
| 34 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.84833192 |
| 35 | adenosine receptor signaling pathway (GO:0001973) | 3.83886037 |
| 36 | low-density lipoprotein particle remodeling (GO:0034374) | 3.77068323 |
| 37 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.76579350 |
| 38 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.73153797 |
| 39 | platelet degranulation (GO:0002576) | 3.71830257 |
| 40 | negative regulation of heart contraction (GO:0045822) | 3.66744061 |
| 41 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.66448887 |
| 42 | vesicle targeting (GO:0006903) | 3.61564734 |
| 43 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.57889931 |
| 44 | regulation of lipoprotein metabolic process (GO:0050746) | 3.55923252 |
| 45 | neuronal action potential propagation (GO:0019227) | 3.55596375 |
| 46 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 3.52138856 |
| 47 | peptide catabolic process (GO:0043171) | 3.50015924 |
| 48 | platelet aggregation (GO:0070527) | 3.48339796 |
| 49 | negative regulation of protein oligomerization (GO:0032460) | 3.37300098 |
| 50 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.35483970 |
| 51 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.34661006 |
| 52 | regulation of memory T cell differentiation (GO:0043380) | 3.30746485 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 3.29928848 |
| 54 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.29886238 |
| 55 | regulation of beta-amyloid formation (GO:1902003) | 3.28032266 |
| 56 | positive regulation of receptor recycling (GO:0001921) | 3.21165289 |
| 57 | regulation of endothelial cell differentiation (GO:0045601) | 3.17059505 |
| 58 | synaptonemal complex organization (GO:0070193) | 3.14914719 |
| 59 | platelet activation (GO:0030168) | 3.14724254 |
| 60 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.12738532 |
| 61 | positive regulation of coagulation (GO:0050820) | 3.11130735 |
| 62 | tonic smooth muscle contraction (GO:0014820) | 3.07161536 |
| 63 | synaptonemal complex assembly (GO:0007130) | 3.04143718 |
| 64 | high-density lipoprotein particle remodeling (GO:0034375) | 3.02811036 |
| 65 | regulation of complement activation (GO:0030449) | 3.02786032 |
| 66 | positive regulation of blood coagulation (GO:0030194) | 3.01173207 |
| 67 | positive regulation of hemostasis (GO:1900048) | 3.01173207 |
| 68 | postsynaptic membrane organization (GO:0001941) | 2.98528013 |
| 69 | activation of protein kinase A activity (GO:0034199) | 2.96560600 |
| 70 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.95447296 |
| 71 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.92015386 |
| 72 | cGMP-mediated signaling (GO:0019934) | 2.90999171 |
| 73 | regulation of protein activation cascade (GO:2000257) | 2.89466232 |
| 74 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.88633544 |
| 75 | phospholipid homeostasis (GO:0055091) | 2.88290623 |
| 76 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.87921183 |
| 77 | eosinophil chemotaxis (GO:0048245) | 2.84724387 |
| 78 | platelet formation (GO:0030220) | 2.83600941 |
| 79 | regulation of blood coagulation (GO:0030193) | 2.79735727 |
| 80 | regulation of hemostasis (GO:1900046) | 2.79735727 |
| 81 | amine catabolic process (GO:0009310) | 2.78873328 |
| 82 | cellular biogenic amine catabolic process (GO:0042402) | 2.78873328 |
| 83 | response to gravity (GO:0009629) | 2.76380619 |
| 84 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.75758855 |
| 85 | neurotransmitter uptake (GO:0001504) | 2.75219683 |
| 86 | protein activation cascade (GO:0072376) | 2.74094138 |
| 87 | negative regulation of blood circulation (GO:1903523) | 2.73495209 |
| 88 | negative regulation of muscle contraction (GO:0045932) | 2.73257905 |
| 89 | termination of signal transduction (GO:0023021) | 2.71953949 |
| 90 | regulation of female receptivity (GO:0045924) | 2.71273758 |
| 91 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.69926501 |
| 92 | lipoxygenase pathway (GO:0019372) | 2.69471661 |
| 93 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.69440402 |
| 94 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.68018353 |
| 95 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.67916664 |
| 96 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.67853736 |
| 97 | regulation of coagulation (GO:0050818) | 2.65780605 |
| 98 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.64851706 |
| 99 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.63136374 |
| 100 | relaxation of smooth muscle (GO:0044557) | 2.62842263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.16657651 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.12268863 |
| 3 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.08850558 |
| 4 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.53568585 |
| 5 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.33055500 |
| 6 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.31339270 |
| 7 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.27278729 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.15490394 |
| 9 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.12634843 |
| 10 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.09915243 |
| 11 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.03998108 |
| 12 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.02012666 |
| 13 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.00351480 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.99964216 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.97932531 |
| 16 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.94223161 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.90666136 |
| 18 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.81014173 |
| 19 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.81014173 |
| 20 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.77242557 |
| 21 | VDR_22108803_ChIP-Seq_LS180_Human | 1.76166814 |
| 22 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.73507762 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.66775990 |
| 24 | GATA1_19941826_ChIP-Seq_K562_Human | 1.66530756 |
| 25 | GATA2_19941826_ChIP-Seq_K562_Human | 1.64737966 |
| 26 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.63309736 |
| 27 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.61031122 |
| 28 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.59370418 |
| 29 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.56934087 |
| 30 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.56062586 |
| 31 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.55900812 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.55846267 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.55631666 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.53217048 |
| 35 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.51846463 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49879007 |
| 37 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.47476365 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46907255 |
| 39 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.45322998 |
| 40 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.41663109 |
| 41 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.40513680 |
| 42 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.40229046 |
| 43 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.39801159 |
| 44 | STAT3_23295773_ChIP-Seq_U87_Human | 1.37298398 |
| 45 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.37221509 |
| 46 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.37221509 |
| 47 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36110407 |
| 48 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.35477811 |
| 49 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.34830142 |
| 50 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.34555468 |
| 51 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33400330 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.32901232 |
| 53 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.30156311 |
| 54 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.30014510 |
| 55 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.29410645 |
| 56 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.29161543 |
| 57 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.26044090 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.25345533 |
| 59 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25242784 |
| 60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24217939 |
| 61 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24101845 |
| 62 | TCF4_23295773_ChIP-Seq_U87_Human | 1.20419044 |
| 63 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.20373237 |
| 64 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.18214523 |
| 65 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.16964844 |
| 66 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.14485787 |
| 67 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.13896349 |
| 68 | AR_25329375_ChIP-Seq_VCAP_Human | 1.13743627 |
| 69 | P300_19829295_ChIP-Seq_ESCs_Human | 1.13038372 |
| 70 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12008644 |
| 71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11989204 |
| 72 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.11867897 |
| 73 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10726085 |
| 74 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.09553863 |
| 75 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.08977630 |
| 76 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06082059 |
| 77 | TP53_16413492_ChIP-PET_HCT116_Human | 1.05651013 |
| 78 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04995629 |
| 79 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.04811808 |
| 80 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.04773070 |
| 81 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.03154676 |
| 82 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02803249 |
| 83 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.01755859 |
| 84 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.01641601 |
| 85 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00785674 |
| 86 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.00740602 |
| 87 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.98537532 |
| 88 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.98413652 |
| 89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97799816 |
| 90 | CJUN_26792858_Chip-Seq_BT549_Human | 0.97333864 |
| 91 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96981380 |
| 92 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95798591 |
| 93 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.95457478 |
| 94 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95244735 |
| 95 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.94855385 |
| 96 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.94822639 |
| 97 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.93998671 |
| 98 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.93899131 |
| 99 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93732551 |
| 100 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.93545734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 6.60800139 |
| 2 | MP0002638_abnormal_pupillary_reflex | 5.52033590 |
| 3 | MP0001661_extended_life_span | 4.87285435 |
| 4 | MP0008004_abnormal_stomach_pH | 3.47762640 |
| 5 | MP0004510_myositis | 3.07534297 |
| 6 | MP0003136_yellow_coat_color | 2.78731449 |
| 7 | MP0005275_abnormal_skin_tensile | 2.78613482 |
| 8 | MP0000579_abnormal_nail_morphology | 2.43337048 |
| 9 | MP0003011_delayed_dark_adaptation | 2.43257442 |
| 10 | MP0003724_increased_susceptibility_to | 2.30846363 |
| 11 | MP0002736_abnormal_nociception_after | 2.27499868 |
| 12 | MP0000013_abnormal_adipose_tissue | 2.12242284 |
| 13 | MP0006054_spinal_hemorrhage | 2.10388640 |
| 14 | MP0003950_abnormal_plasma_membrane | 1.91381888 |
| 15 | MP0004084_abnormal_cardiac_muscle | 1.90705471 |
| 16 | MP0000230_abnormal_systemic_arterial | 1.81881549 |
| 17 | MP0000465_gastrointestinal_hemorrhage | 1.80529860 |
| 18 | MP0001879_abnormal_lymphatic_vessel | 1.74844039 |
| 19 | MP0004036_abnormal_muscle_relaxation | 1.69402894 |
| 20 | MP0005171_absent_coat_pigmentation | 1.66455431 |
| 21 | MP0003329_amyloid_beta_deposits | 1.66005972 |
| 22 | MP0001502_abnormal_circadian_rhythm | 1.64013899 |
| 23 | MP0004130_abnormal_muscle_cell | 1.62215977 |
| 24 | MP0001851_eye_inflammation | 1.58554264 |
| 25 | MP0001835_abnormal_antigen_presentation | 1.58104106 |
| 26 | MP0000343_altered_response_to | 1.56615214 |
| 27 | MP0003638_abnormal_response/metabolism_ | 1.56181789 |
| 28 | MP0005167_abnormal_blood-brain_barrier | 1.54945146 |
| 29 | MP0002132_abnormal_respiratory_system | 1.52498095 |
| 30 | MP0000383_abnormal_hair_follicle | 1.51931593 |
| 31 | MP0003566_abnormal_cell_adhesion | 1.50656314 |
| 32 | MP0004272_abnormal_basement_membrane | 1.48655823 |
| 33 | MP0010368_abnormal_lymphatic_system | 1.44991731 |
| 34 | MP0004215_abnormal_myocardial_fiber | 1.44691500 |
| 35 | MP0009053_abnormal_anal_canal | 1.42270231 |
| 36 | MP0001853_heart_inflammation | 1.41752359 |
| 37 | MP0003303_peritoneal_inflammation | 1.41577779 |
| 38 | MP0004947_skin_inflammation | 1.35887047 |
| 39 | MP0003828_pulmonary_edema | 1.34884041 |
| 40 | MP0000685_abnormal_immune_system | 1.31958896 |
| 41 | MP0001968_abnormal_touch/_nociception | 1.26828774 |
| 42 | MP0005387_immune_system_phenotype | 1.26106995 |
| 43 | MP0001790_abnormal_immune_system | 1.26106995 |
| 44 | MP0005551_abnormal_eye_electrophysiolog | 1.25096066 |
| 45 | MP0005365_abnormal_bile_salt | 1.24740019 |
| 46 | MP0008775_abnormal_heart_ventricle | 1.23812089 |
| 47 | MP0005058_abnormal_lysosome_morphology | 1.23578374 |
| 48 | MP0005671_abnormal_response_to | 1.23254931 |
| 49 | MP0010329_abnormal_lipoprotein_level | 1.20043346 |
| 50 | MP0005084_abnormal_gallbladder_morpholo | 1.08487900 |
| 51 | MP0005253_abnormal_eye_physiology | 1.08384024 |
| 52 | MP0009763_increased_sensitivity_to | 1.06527769 |
| 53 | MP0002138_abnormal_hepatobiliary_system | 1.01052055 |
| 54 | MP0005595_abnormal_vascular_smooth | 1.01004381 |
| 55 | MP0000249_abnormal_blood_vessel | 1.00013889 |
| 56 | MP0001800_abnormal_humoral_immune | 0.98654110 |
| 57 | MP0003646_muscle_fatigue | 0.97981590 |
| 58 | MP0005620_abnormal_muscle_contractility | 0.92078291 |
| 59 | MP0002972_abnormal_cardiac_muscle | 0.91554640 |
| 60 | MP0008872_abnormal_physiological_respon | 0.91346233 |
| 61 | MP0002733_abnormal_thermal_nociception | 0.90091036 |
| 62 | MP0003091_abnormal_cell_migration | 0.89698560 |
| 63 | MP0006276_abnormal_autonomic_nervous | 0.89008598 |
| 64 | MP0000604_amyloidosis | 0.88778545 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 0.86739382 |
| 66 | MP0005000_abnormal_immune_tolerance | 0.85928602 |
| 67 | MP0000751_myopathy | 0.83084472 |
| 68 | MP0001664_abnormal_digestion | 0.81487820 |
| 69 | MP0005085_abnormal_gallbladder_physiolo | 0.78242484 |
| 70 | MP0008438_abnormal_cutaneous_collagen | 0.76903177 |
| 71 | MP0005023_abnormal_wound_healing | 0.76730096 |
| 72 | MP0002090_abnormal_vision | 0.75954305 |
| 73 | MP0005410_abnormal_fertilization | 0.73289544 |
| 74 | MP0002128_abnormal_blood_circulation | 0.73246213 |
| 75 | MP0003879_abnormal_hair_cell | 0.72690518 |
| 76 | MP0003252_abnormal_bile_duct | 0.72338478 |
| 77 | MP0008569_lethality_at_weaning | 0.71121777 |
| 78 | MP0003045_fibrosis | 0.70003826 |
| 79 | MP0002095_abnormal_skin_pigmentation | 0.67856572 |
| 80 | MP0010155_abnormal_intestine_physiology | 0.66641320 |
| 81 | MP0002398_abnormal_bone_marrow | 0.66511448 |
| 82 | MP0008874_decreased_physiological_sensi | 0.66203258 |
| 83 | MP0002234_abnormal_pharynx_morphology | 0.65991339 |
| 84 | MP0000749_muscle_degeneration | 0.65658844 |
| 85 | MP0010678_abnormal_skin_adnexa | 0.64355563 |
| 86 | MP0005646_abnormal_pituitary_gland | 0.63651552 |
| 87 | MP0002452_abnormal_antigen_presenting | 0.63155656 |
| 88 | MP0005397_hematopoietic_system_phenotyp | 0.62935972 |
| 89 | MP0001545_abnormal_hematopoietic_system | 0.62935972 |
| 90 | MP0005165_increased_susceptibility_to | 0.62919745 |
| 91 | MP0009642_abnormal_blood_homeostasis | 0.62870201 |
| 92 | MP0001663_abnormal_digestive_system | 0.61721194 |
| 93 | MP0004484_altered_response_of | 0.61614491 |
| 94 | MP0005670_abnormal_white_adipose | 0.60908930 |
| 95 | MP0002723_abnormal_immune_serum | 0.60477264 |
| 96 | MP0002118_abnormal_lipid_homeostasis | 0.60143050 |
| 97 | MP0001756_abnormal_urination | 0.59150065 |
| 98 | MP0002089_abnormal_postnatal_growth/wei | 0.58495213 |
| 99 | MP0002909_abnormal_adrenal_gland | 0.58448763 |
| 100 | MP0001970_abnormal_pain_threshold | 0.57840032 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 8.32743332 |
| 2 | Menorrhagia (HP:0000132) | 7.48698013 |
| 3 | Petechiae (HP:0000967) | 7.30823200 |
| 4 | Conjunctival telangiectasia (HP:0000524) | 6.80030723 |
| 5 | Increased mean platelet volume (HP:0011877) | 6.66324288 |
| 6 | Purpura (HP:0000979) | 6.59167885 |
| 7 | Abnormal platelet volume (HP:0011876) | 6.15934670 |
| 8 | Epistaxis (HP:0000421) | 5.77094113 |
| 9 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 5.64911094 |
| 10 | Gingival bleeding (HP:0000225) | 5.28000267 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.93754182 |
| 12 | Abnormality of binocular vision (HP:0011514) | 4.23041190 |
| 13 | Diplopia (HP:0000651) | 4.23041190 |
| 14 | Absent phalangeal crease (HP:0006109) | 4.02216424 |
| 15 | Abnormal platelet function (HP:0011869) | 4.01960276 |
| 16 | Impaired platelet aggregation (HP:0003540) | 4.01960276 |
| 17 | Follicular hyperkeratosis (HP:0007502) | 3.81885960 |
| 18 | Abnormal finger flexion creases (HP:0006143) | 3.52591857 |
| 19 | Spontaneous hematomas (HP:0007420) | 3.50070536 |
| 20 | Congenital, generalized hypertrichosis (HP:0004540) | 3.37991270 |
| 21 | Mitral stenosis (HP:0001718) | 3.28388926 |
| 22 | Coronal craniosynostosis (HP:0004440) | 3.24391373 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 3.17582191 |
| 24 | Pili torti (HP:0003777) | 2.93568336 |
| 25 | Poikilocytosis (HP:0004447) | 2.85794569 |
| 26 | Mucosal telangiectasiae (HP:0100579) | 2.83089384 |
| 27 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.77932070 |
| 28 | Neonatal respiratory distress (HP:0002643) | 2.75499144 |
| 29 | Abnormal pupillary function (HP:0007686) | 2.71390815 |
| 30 | Short 5th finger (HP:0009237) | 2.70994255 |
| 31 | Thyroid-stimulating hormone excess (HP:0002925) | 2.65516460 |
| 32 | Joint hemorrhage (HP:0005261) | 2.61846546 |
| 33 | Bruising susceptibility (HP:0000978) | 2.60320895 |
| 34 | Spontaneous abortion (HP:0005268) | 2.58534951 |
| 35 | Bundle branch block (HP:0011710) | 2.56797523 |
| 36 | Acanthocytosis (HP:0001927) | 2.47310991 |
| 37 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 2.43260671 |
| 38 | Polyphagia (HP:0002591) | 2.40075472 |
| 39 | Xanthomatosis (HP:0000991) | 2.38122207 |
| 40 | Papillary thyroid carcinoma (HP:0002895) | 2.37508916 |
| 41 | Abnormal hair laboratory examination (HP:0003328) | 2.37446014 |
| 42 | Paralysis (HP:0003470) | 2.37272217 |
| 43 | Exercise-induced myalgia (HP:0003738) | 2.35224118 |
| 44 | Atonic seizures (HP:0010819) | 2.33456252 |
| 45 | Joint swelling (HP:0001386) | 2.32743775 |
| 46 | Muscle fiber splitting (HP:0003555) | 2.21799751 |
| 47 | Supernumerary nipples (HP:0002558) | 2.19790281 |
| 48 | Broad foot (HP:0001769) | 2.19402059 |
| 49 | Abnormality of lateral ventricle (HP:0030047) | 2.14858503 |
| 50 | Menstrual irregularities (HP:0000858) | 2.11116512 |
| 51 | Abnormal auditory evoked potentials (HP:0006958) | 2.10909824 |
| 52 | Increased density of long bones (HP:0006392) | 2.10276862 |
| 53 | Growth hormone excess (HP:0000845) | 2.07965148 |
| 54 | Abnormality of the anterior chamber (HP:0000593) | 2.07166261 |
| 55 | Basal ganglia calcification (HP:0002135) | 2.05196540 |
| 56 | Neuroendocrine neoplasm (HP:0100634) | 2.05109923 |
| 57 | Blue irides (HP:0000635) | 2.01546321 |
| 58 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.98076654 |
| 59 | Status epilepticus (HP:0002133) | 1.93819941 |
| 60 | Generalized tonic-clonic seizures (HP:0002069) | 1.93170281 |
| 61 | Dyschromatopsia (HP:0007641) | 1.91369958 |
| 62 | Split foot (HP:0001839) | 1.90153065 |
| 63 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.82928177 |
| 64 | Hemiparesis (HP:0001269) | 1.81444544 |
| 65 | Neoplasm of the heart (HP:0100544) | 1.80475122 |
| 66 | Nemaline bodies (HP:0003798) | 1.80091241 |
| 67 | Woolly hair (HP:0002224) | 1.78967086 |
| 68 | Pheochromocytoma (HP:0002666) | 1.77262003 |
| 69 | Spastic paraparesis (HP:0002313) | 1.76896535 |
| 70 | Upper limb muscle weakness (HP:0003484) | 1.76849338 |
| 71 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.76750106 |
| 72 | Abolished electroretinogram (ERG) (HP:0000550) | 1.76578628 |
| 73 | Decreased central vision (HP:0007663) | 1.75513193 |
| 74 | Vascular calcification (HP:0004934) | 1.75491351 |
| 75 | Hyperpituitarism (HP:0010514) | 1.73920095 |
| 76 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.73457379 |
| 77 | Postural tremor (HP:0002174) | 1.73353491 |
| 78 | Testicular neoplasm (HP:0010788) | 1.72223401 |
| 79 | Increased cerebral lipofuscin (HP:0011813) | 1.71733211 |
| 80 | Wide anterior fontanel (HP:0000260) | 1.71708406 |
| 81 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.70943988 |
| 82 | Hypoplasia of the iris (HP:0007676) | 1.70014234 |
| 83 | Conjugated hyperbilirubinemia (HP:0002908) | 1.68828020 |
| 84 | Increased variability in muscle fiber diameter (HP:0003557) | 1.64248958 |
| 85 | Cardiovascular calcification (HP:0011915) | 1.63261313 |
| 86 | Striae distensae (HP:0001065) | 1.62083860 |
| 87 | Focal seizures (HP:0007359) | 1.61410541 |
| 88 | Ventricular fibrillation (HP:0001663) | 1.60728362 |
| 89 | Generalized myoclonic seizures (HP:0002123) | 1.60311693 |
| 90 | Hypercortisolism (HP:0001578) | 1.59172134 |
| 91 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.58264710 |
| 92 | Termporal pattern (HP:0011008) | 1.56743050 |
| 93 | Insidious onset (HP:0003587) | 1.56743050 |
| 94 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.55417799 |
| 95 | Vertigo (HP:0002321) | 1.52658595 |
| 96 | Hepatosplenomegaly (HP:0001433) | 1.52054424 |
| 97 | Gait imbalance (HP:0002141) | 1.51856131 |
| 98 | Muscle fiber inclusion bodies (HP:0100299) | 1.51370250 |
| 99 | Intellectual disability, mild (HP:0001256) | 1.50211698 |
| 100 | Biliary tract neoplasm (HP:0100574) | 1.49189533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYLK | 3.31420351 |
| 2 | PDK2 | 3.21461935 |
| 3 | RIPK4 | 2.96985759 |
| 4 | MST4 | 2.93086527 |
| 5 | BMX | 2.88473371 |
| 6 | PTK2B | 2.78651748 |
| 7 | STK38L | 2.74915979 |
| 8 | PIK3CG | 2.71834476 |
| 9 | MAP4K2 | 2.66973181 |
| 10 | FGR | 2.52921230 |
| 11 | STK24 | 2.23728568 |
| 12 | OBSCN | 2.20521794 |
| 13 | TEC | 2.19283362 |
| 14 | CSF1R | 2.09526330 |
| 15 | MKNK2 | 2.02937654 |
| 16 | FRK | 1.99782695 |
| 17 | BTK | 1.97359297 |
| 18 | STK3 | 1.83384928 |
| 19 | SYK | 1.79259716 |
| 20 | PHKG1 | 1.75202948 |
| 21 | PHKG2 | 1.75202948 |
| 22 | MAPKAPK3 | 1.66779186 |
| 23 | TRPM7 | 1.58466334 |
| 24 | PLK2 | 1.57319698 |
| 25 | CSK | 1.56866239 |
| 26 | EIF2AK1 | 1.54414041 |
| 27 | BMPR1B | 1.40138044 |
| 28 | EPHA3 | 1.36173937 |
| 29 | BLK | 1.35955084 |
| 30 | BMPR2 | 1.34522814 |
| 31 | GRK5 | 1.32046642 |
| 32 | JAK3 | 1.27417242 |
| 33 | DYRK1A | 1.27248036 |
| 34 | MAPK12 | 1.26917628 |
| 35 | FER | 1.13998444 |
| 36 | NEK9 | 1.11467253 |
| 37 | TIE1 | 1.09154622 |
| 38 | ZAP70 | 1.06610393 |
| 39 | ILK | 1.05273981 |
| 40 | GRK1 | 1.04309718 |
| 41 | EPHB2 | 1.03443844 |
| 42 | IKBKB | 0.99952594 |
| 43 | TAOK3 | 0.96243331 |
| 44 | PAK3 | 0.92297846 |
| 45 | LYN | 0.91634432 |
| 46 | PKN1 | 0.89798191 |
| 47 | MARK3 | 0.89345731 |
| 48 | ADRBK2 | 0.89306081 |
| 49 | HCK | 0.80262678 |
| 50 | FES | 0.79578269 |
| 51 | MAPK7 | 0.79026901 |
| 52 | LMTK2 | 0.77373931 |
| 53 | MKNK1 | 0.75635960 |
| 54 | JAK1 | 0.74724586 |
| 55 | TNIK | 0.73919336 |
| 56 | DDR2 | 0.72863861 |
| 57 | PDK1 | 0.71393789 |
| 58 | ITK | 0.70675170 |
| 59 | NLK | 0.70351661 |
| 60 | TLK1 | 0.69282077 |
| 61 | TNK2 | 0.67404455 |
| 62 | SIK1 | 0.66909196 |
| 63 | PRKACG | 0.65191506 |
| 64 | IRAK1 | 0.64521505 |
| 65 | MAP3K12 | 0.64019185 |
| 66 | GRK6 | 0.63636262 |
| 67 | PDGFRB | 0.62070423 |
| 68 | DAPK3 | 0.61869422 |
| 69 | ADRBK1 | 0.59543948 |
| 70 | MAP3K5 | 0.59450357 |
| 71 | MAPK13 | 0.57460601 |
| 72 | PRKG1 | 0.57320052 |
| 73 | ROCK1 | 0.57072038 |
| 74 | PDPK1 | 0.52214215 |
| 75 | TXK | 0.52078809 |
| 76 | PRKCE | 0.51949019 |
| 77 | SGK2 | 0.51040238 |
| 78 | IRAK2 | 0.49473330 |
| 79 | IGF1R | 0.48928651 |
| 80 | PRKD1 | 0.48910767 |
| 81 | BRSK2 | 0.47557866 |
| 82 | ABL2 | 0.47515179 |
| 83 | DAPK2 | 0.45040879 |
| 84 | ABL1 | 0.41705157 |
| 85 | GSK3A | 0.40201943 |
| 86 | RET | 0.39817576 |
| 87 | CCNB1 | 0.39603209 |
| 88 | PRKACA | 0.39323847 |
| 89 | MAP3K10 | 0.38795158 |
| 90 | PIM2 | 0.36638550 |
| 91 | PAK1 | 0.36420977 |
| 92 | VRK1 | 0.35932983 |
| 93 | CAMK2A | 0.35415537 |
| 94 | SIK3 | 0.35255043 |
| 95 | PRKACB | 0.34664800 |
| 96 | MAPKAPK2 | 0.31694939 |
| 97 | MAP2K1 | 0.31502079 |
| 98 | PRKCZ | 0.30400270 |
| 99 | FYN | 0.30017006 |
| 100 | PRKCA | 0.29969304 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Platelet activation_Homo sapiens_hsa04611 | 3.84976646 |
| 2 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 3.24739971 |
| 3 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 3.10787625 |
| 4 | ABC transporters_Homo sapiens_hsa02010 | 3.04149264 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.67291351 |
| 6 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.52897833 |
| 7 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.46463725 |
| 8 | Histidine metabolism_Homo sapiens_hsa00340 | 2.45310081 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.37221218 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.27304619 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.83629195 |
| 12 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.83046059 |
| 13 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.77246400 |
| 14 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.76288615 |
| 15 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.57592984 |
| 16 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.56123769 |
| 17 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.54329452 |
| 18 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.54190171 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.48236288 |
| 20 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.44114894 |
| 21 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.41151804 |
| 22 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.35556250 |
| 23 | Circadian rhythm_Homo sapiens_hsa04710 | 1.35466754 |
| 24 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.33157781 |
| 25 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.29918431 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.28859806 |
| 27 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.28352039 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.25935042 |
| 29 | Olfactory transduction_Homo sapiens_hsa04740 | 1.25825802 |
| 30 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.23201224 |
| 31 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.22024798 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.21671120 |
| 33 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.13752187 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.11200251 |
| 35 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.09749554 |
| 36 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.08600710 |
| 37 | Lysine degradation_Homo sapiens_hsa00310 | 1.07399390 |
| 38 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.06341865 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.00659473 |
| 40 | Gap junction_Homo sapiens_hsa04540 | 0.96668552 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.96112472 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 0.94770810 |
| 43 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.92512934 |
| 44 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.89490906 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.89484835 |
| 46 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.88663276 |
| 47 | Focal adhesion_Homo sapiens_hsa04510 | 0.85520664 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84117282 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.82996153 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81583059 |
| 51 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.80787499 |
| 52 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.80692413 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79096227 |
| 54 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.78465498 |
| 55 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.78057782 |
| 56 | Malaria_Homo sapiens_hsa05144 | 0.77218697 |
| 57 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72703618 |
| 58 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.71850633 |
| 59 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68930174 |
| 60 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62793618 |
| 61 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.59114314 |
| 62 | GABAergic synapse_Homo sapiens_hsa04727 | 0.59049837 |
| 63 | Amoebiasis_Homo sapiens_hsa05146 | 0.57610185 |
| 64 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.56568112 |
| 65 | Endocytosis_Homo sapiens_hsa04144 | 0.56412748 |
| 66 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.56245453 |
| 67 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55868056 |
| 68 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54225460 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.53189602 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52395135 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52278872 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51681453 |
| 73 | Circadian entrainment_Homo sapiens_hsa04713 | 0.48635904 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.46941408 |
| 75 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46738773 |
| 76 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.45975837 |
| 77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.45188452 |
| 78 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44727146 |
| 79 | Salivary secretion_Homo sapiens_hsa04970 | 0.43832959 |
| 80 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.43627229 |
| 81 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.42583322 |
| 82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40782161 |
| 83 | Phagosome_Homo sapiens_hsa04145 | 0.39995834 |
| 84 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39442215 |
| 85 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.38944300 |
| 86 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.38607833 |
| 87 | Long-term depression_Homo sapiens_hsa04730 | 0.36973967 |
| 88 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36896234 |
| 89 | Peroxisome_Homo sapiens_hsa04146 | 0.36701127 |
| 90 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.35759037 |
| 91 | Alcoholism_Homo sapiens_hsa05034 | 0.35614269 |
| 92 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.34457696 |
| 93 | Morphine addiction_Homo sapiens_hsa05032 | 0.32450076 |
| 94 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.32079307 |
| 95 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31851125 |
| 96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.30280082 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.28015365 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.27678948 |
| 99 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.27598471 |
| 100 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.26832192 |

